NCT/Study#

NCT04293185 /

HGB210-JTCC

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Sickle Cell Disease

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Sickle Cell Disease

DISEASE GROUP:
Transplant
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: